Cvs Health is a healthcare plan company located in Rhode Island, United States, which is part of the Healthcare sector, and is traded under the ticker CVS on the NYSE exchange.
Cvs Health stock last closed at $66.71, up 2.58% from the previous day, and has decreased 1.48% in one year. It has overperformed other stocks in the Healthcare Plans industry by 0.1 percentage points. Cvs Health stock is currently +53.15% from its 52-week low of $43.56, and -6.63% from its 52-week high of $71.45.
As of Apr 30, 2025, there are 1.26B shares of CVS outstanding. The market capitalization of CVS is $84.11B. In the past 24 hours, 12.51M CVS shares were traded.
How to Buy Cvs Health Stock
Wondering how to invest in Cvs Health stock? Here's how.
Figure out where to buy Cvs Health stock: You need to choose a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Cvs Health stock.
Create your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Fund your investment account: Select your method of payment and add your details.
Evaluate Cvs Health stock: The Cvs Health ticker symbol is CVS. Is Cvs Health stock a good investment? Should you buy shares of CVS? How do CVS's underlying business fundamentals look? Do top analysts think Cvs Health is a good buy? Why has CVS's stock price moved recently? (Hint: Our stock analysis website can help you understand if CVS is a good stock to buy).
Make your CVS buy order: Decide if you will purchase CVS shares at the current market price or use a limit order to buy CVS stock at a particular price.
Get key alerts regarding your investment in CVS: Create a watchlist to the latest updates on your investment in Cvs Health shares.
Step 1: Figure out where to buy Cvs Health stock
You need an online brokerage account to access the NYSE market and buy CVS shares.
A brokerage account allows you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.
Our preferred brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Tech to Industrials, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
Social investing: eToro boasts a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by opening an account with eToro today. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Create your brokerage account
Now that you've selected the right brokerage, you need to fill out some personal info so you are able to invest in CVS stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Cvs Health stock
After you have figured out the best place to buy Cvs Health stock, it's important to research their stock prior to investing, so you actually wrap your head around the risk as well as the opportunity.
Cvs Health Numbers
CVS Price
$66.71
1w %
1.74%
1y %
-1.48%
5y %
8.38%
P/E
18.18x
P/B
1.11x
P/S
0.23x
PEG
0.65x
Revenue
$372.81B
Earnings
$4.61B
Fore. Rev. Growth
5.16%
Fore. Earn. Growth
27.93%
Market Cap
$84.11B
Next Earnings
N/A
Next Dividend
N/A
CVS Fundamentals
WallStreetZen was built to help everyday investors perform more accurate fundamental analysis in minutes instead of hours.
You can view all of the due diligence checks on CVS's stock page.
Is CVS stock undervalued?
Investors use many financial metrics, analyses, models, and charts to gauge CVS's true value.
Using relative valuations ratios:
CVS could be undervalued based on its P/E ratio of 18.18x, relative to Healthcare Plans industry P/E ratio of 22.98x
CVS may be undervalued based on its P/B ratio of 1.11x, relative to Healthcare Plans industry P/B ratio of 2.44x
CVS could be undervalued based on its PEG ratio of 0.65x
Total CVS debt is lower than 5 years ago, relative to shareholder equity.
Negative Health Checks:
CVS's operating cash flow of $9.11B allows it to safely service it's debt of $82.92B.
CVS profit margin has gone down from 2.3% to 1.2% in the past year.
CVS has a relatively high debt to equity ratio of 2.35.
There are more long-term liabilities than short-term assets on the CVS balance sheet.
CVS earnings of $9.13B is not enough to cover its interest payments.
There are more short-term liabilities than short-term assets on the CVS balance sheet.
Is it a good time to buy CVS stock, according to analysts?
Out of 13 Wall Street analysts who give forecasts on CVS, the consensus analyst rating on Cvs Health is a Strong Buy
It's important to note that analyst forecasts are not stock recommendations, nor are they financial advice.
Most Recent CVS Analyst Forecasts
Stephen Baxter, a top 33% analyst from Wells Fargo maintains CVS with a strong buy rating and raises their CVS price target from $68.00 to $73.00, on Feb 13, 2025.
Andrew Mok, a bottom 6% analyst from Barclays maintains CVS with a strong buy rating and raises their CVS price target from $71.00 to $73.00, on Feb 13, 2025.
Michael Cherny, a top 21% analyst from Leerink Partners upgrades CVS to a buy rating and raises their CVS price target from $55.00 to $75.00, on Feb 13, 2025.
Elizabeth Anderson, a bottom 9% analyst from Evercore ISI Group maintains CVS with a buy rating and raises their CVS price target from $60.00 to $65.00, on Jan 27, 2025.
George Hill, a top 10% analyst from Deutsche Bank upgrades CVS to a strong buy rating and maintains their CVS price target from $66.00 to $66.00, on Dec 3, 2024.
Last year, CVS earnings were $4.61B. Over the last 5 year, CVS's earnings have gone up by -6.37% per year. This was slower than the Healthcare Plans industry average of 1.74%.
Last year, CVS revenue was $372.81B. In the last 5 year, CVS's revenue has grown by 7.74% per year. This was slower than the Healthcare Plans industry average of 11.13%.
No, Cvs Health doesn't provide an income stream by paying out dividends.
What do other investors have to say about CVS?
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your CVS buy order
There are two primary options:
Market order: A market order is an order to buy or sell a security at the best available price. Market orders are usually the best for newer investors.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open Trade button and eToro will place your order.
If you need additional assistance buying stocks on eToro, watch the helpful video below:
How much does it cost to buy one Cvs Health share?
As of Apr 30, 2025, it costs $66.71 to buy one share of Cvs Health stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.15 shares of CVS.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.